| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |